PCSK9 and coronary artery disorder: The selected genetic instruments were validated by analyzing the correlations between drug-related SNPs and the coronary heart disease as the positive control (Pvalues for HMGCR and PCSK9 were 3.291E-05 and 2.000E-10, respectively) (Figure 3, Supplementary Figures 13-18).